{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:30:17Z","timestamp":1793953817441,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7992","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2023,12,21]]},"DOI":"10.1038\/s41586-023-06809-8","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T12:02:28Z","timestamp":1702468948000},"page":"630-638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization"],"prefix":"10.1038","volume":"624","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6200-3229","authenticated-orcid":false,"given":"Tong","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7102-3360","authenticated-orcid":false,"given":"Zhouguang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanlong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9769-5141","authenticated-orcid":false,"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4246-8889","authenticated-orcid":false,"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1721-8922","authenticated-orcid":false,"given":"Di","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9189-602X","authenticated-orcid":false,"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8476-4320","authenticated-orcid":false,"given":"Hengliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9975-8978","authenticated-orcid":false,"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9154-5556","authenticated-orcid":false,"given":"Guanghui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-3187","authenticated-orcid":false,"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"6809_CR1","doi-asserted-by":"publisher","first-page":"E312","DOI":"10.1016\/S2542-5196(20)30168-6","volume":"4","author":"H Lambert","year":"2020","unstructured":"Lambert, H. et al. COVID-19 as a global challenge: towards an inclusive and sustainable future. Lancet Planet Health 4, E312\u2013E314 (2020).","journal-title":"Lancet Planet Health"},{"key":"6809_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","volume":"586","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature 586, 572\u2013577 (2020).","journal-title":"Nature"},{"key":"6809_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.cell.2020.07.024","volume":"182","author":"NN Zhang","year":"2020","unstructured":"Zhang, N. N. et al. A thermostable mRNA vaccine against COVID-19. Cell 182, 1271\u20131283.e1216 (2020).","journal-title":"Cell"},{"key":"6809_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","volume":"183","author":"AO Hassan","year":"2020","unstructured":"Hassan, A. O. et al. A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2. Cell 183, 169\u2013184.e113 (2020).","journal-title":"Cell"},{"key":"6809_CR5","doi-asserted-by":"publisher","first-page":"8707","DOI":"10.1016\/j.vaccine.2007.10.035","volume":"25","author":"JP Amorij","year":"2007","unstructured":"Amorij, J. P. et al. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB\/c mice. Vaccine 25, 8707\u20138717 (2007).","journal-title":"Vaccine"},{"key":"6809_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/d41586-022-02824-3","volume":"609","author":"E Waltz","year":"2022","unstructured":"Waltz, E. How nasal-spray vaccines could change the pandemic. Nature 609, 240\u2013242 (2022).","journal-title":"Nature"},{"key":"6809_CR7","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1016\/S1473-3099(20)30484-9","volume":"20","author":"E Petersen","year":"2020","unstructured":"Petersen, E. et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect. Dis. 20, e238\u2013e244 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"6809_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265\u2013269 (2020).","journal-title":"Nature"},{"key":"6809_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.abc1932","volume":"369","author":"Q Gao","year":"2020","unstructured":"Gao, Q. et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science 369, 77\u201381 (2020).","journal-title":"Science"},{"key":"6809_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","volume":"182","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2. Cell 182, 713\u2013721.e719 (2020).","journal-title":"Cell"},{"key":"6809_CR11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","volume":"182","author":"L Dai","year":"2020","unstructured":"Dai, L. et al. A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS. Cell 182, 722\u2013733.e711 (2020).","journal-title":"Cell"},{"key":"6809_CR12","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","volume":"383","author":"KS Corbett","year":"2020","unstructured":"Corbett, K. S. et al. Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. N. Engl. J. Med. 383, 1544\u20131555 (2020).","journal-title":"N. Engl. J. Med."},{"key":"6809_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","volume":"396","author":"PM Folegatti","year":"2020","unstructured":"Folegatti, P. M. et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial. Lancet 396, 467\u2013478 (2020).","journal-title":"Lancet"},{"key":"6809_CR14","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","volume":"67","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2. Sci. Bull. 67, 1372\u20131387 (2022).","journal-title":"Sci. Bull."},{"key":"6809_CR15","doi-asserted-by":"publisher","first-page":"109400","DOI":"10.1016\/j.celrep.2021.109400","volume":"36","author":"TL Bricker","year":"2021","unstructured":"Bricker, T. L. et al. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters. Cell Rep. 36, 109400 (2021).","journal-title":"Cell Rep."},{"key":"6809_CR16","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1016\/j.cell.2022.11.006","volume":"185","author":"C Le Nouen","year":"2022","unstructured":"Le Nouen, C. et al. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys. Cell 185, 4811\u20134825.e4817 (2022).","journal-title":"Cell"},{"key":"6809_CR17","doi-asserted-by":"crossref","unstructured":"Ponce-de-Leon, S. et al. Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico. Preprint at medRxiv 10.1101\/2022.02.08.22270676 (2022).","DOI":"10.1101\/2022.02.08.22270676"},{"key":"6809_CR18","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","volume":"185","author":"S Afkhami","year":"2022","unstructured":"Afkhami, S. et al. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell 185, 896\u2013915.e819 (2022).","journal-title":"Cell"},{"key":"6809_CR19","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/S1473-3099(21)00396-0","volume":"21","author":"S Wu","year":"2021","unstructured":"Wu, S. et al. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial. Lancet Infect. Dis. 21, 1654\u20131664 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"6809_CR20","doi-asserted-by":"publisher","first-page":"e155655","DOI":"10.1172\/jci.insight.155655","volume":"7","author":"M Jeyanathan","year":"2022","unstructured":"Jeyanathan, M. et al. Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans. JCI Insight 7, e155655 (2022).","journal-title":"JCI Insight"},{"key":"6809_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11095-012-0891-5","volume":"30","author":"NK Kunda","year":"2013","unstructured":"Kunda, N. K., Somavarapu, S., Gordon, S. B., Hutcheon, G. A. & Saleem, I. Y. Nanocarriers targeting dendritic cells for pulmonary vaccine delivery. Pharm. Res. 30, 325\u2013341 (2013).","journal-title":"Pharm. Res."},{"key":"6809_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrd2153","volume":"6","author":"JS Patton","year":"2007","unstructured":"Patton, J. S. & Byron, P. R. Inhaling medicines: delivering drugs to the body through the lungs. Nat. Rev. Drug Discov. 6, 67\u201374 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"6809_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/mi.2009.16","volume":"2","author":"HH Smits","year":"2009","unstructured":"Smits, H. H. et al. Cholera toxin B suppresses allergic inflammation through induction of secretory IgA. Mucosal Immunol. 2, 331\u2013339 (2009).","journal-title":"Mucosal Immunol."},{"key":"6809_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0665-z","volume":"9","author":"A Wakabayashi","year":"2018","unstructured":"Wakabayashi, A., Shimizu, M., Shinya, E. & Takahashi, H. HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA. Cell Death Dis. 9, 631 (2018).","journal-title":"Cell Death Dis."},{"key":"6809_CR25","doi-asserted-by":"publisher","first-page":"e2002940","DOI":"10.1002\/adma.202002940","volume":"32","author":"C Pan","year":"2020","unstructured":"Pan, C. et al. Biosynthesis of self-assembled proteinaceous nanoparticles for vaccination. Adv. Mater. 32, e2002940 (2020).","journal-title":"Adv. Mater."},{"key":"6809_CR26","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/nbt1332","volume":"25","author":"ST Reddy","year":"2007","unstructured":"Reddy, S. T. et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat. Biotechnol. 25, 1159\u20131164 (2007).","journal-title":"Nat. Biotechnol."},{"key":"6809_CR27","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s12274-021-3713-4","volume":"15","author":"X Li","year":"2022","unstructured":"Li, X. et al. Orthogonal modular biosynthesis of nanoscale conjugate vaccines for vaccination against infection. Nano Res. 15, 1645\u20131653 (2022).","journal-title":"Nano Res."},{"key":"6809_CR28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1080\/14760584.2021.1903878","volume":"21","author":"R Heida","year":"2022","unstructured":"Heida, R., Hinrichs, W. L. & Frijlink, H. W., Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19. Expert Rev. Vaccines 21, 957\u2013974 (2022).","journal-title":"Expert Rev. Vaccines"},{"key":"6809_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1517\/17425247.4.6.651","volume":"4","author":"B Pulliam","year":"2007","unstructured":"Pulliam, B., Sung, J. C. & Edwards, D. A. Design of nanoparticle-based dry powder pulmonary vaccines. Expert Opin. Drug Deliv. 4, 651\u2013663 (2007).","journal-title":"Expert Opin. Drug Deliv."},{"key":"6809_CR30","doi-asserted-by":"publisher","first-page":"eaay7735","DOI":"10.1126\/sciadv.aay7735","volume":"6","author":"XB Xi","year":"2020","unstructured":"Xi, X. B. et al. Self-healing microcapsules synergetically modulate immunization microenvironments for potent cancer vaccination. Sci. Adv. 6, eaay7735 (2020).","journal-title":"Sci. Adv."},{"key":"6809_CR31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41551-020-00624-6","volume":"5","author":"XL Xie","year":"2021","unstructured":"Xie, X. L. et al. Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen. Nat. Biomed. Eng. 5, 414\u2013428 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"6809_CR32","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","volume":"26","author":"M Liao","year":"2020","unstructured":"Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 26, 842\u2013844 (2020).","journal-title":"Nat. Med."},{"key":"6809_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/imm.13262","volume":"162","author":"SM Toor","year":"2021","unstructured":"Toor, S. M., Saleh, R., Sasidharan Nair, V., Taha, R. Z. & Elkord, E. T-cell responses and therapies against SARS-CoV-2 infection. Immunology 162, 30\u201343 (2021).","journal-title":"Immunology"},{"key":"6809_CR34","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489\u20131501.e1415 (2020).","journal-title":"Cell"},{"key":"6809_CR35","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s41590-022-01253-8","volume":"23","author":"D Yu","year":"2022","unstructured":"Yu, D., Walker, L. S. K., Liu, Z., Linterman, M. A. & Li, Z. Targeting TFH cells in human diseases and vaccination: rationale and practice. Nat. Immunol. 23, 1157\u20131168 (2022).","journal-title":"Nat. Immunol."},{"key":"6809_CR36","doi-asserted-by":"publisher","first-page":"104298","DOI":"10.1016\/j.ebiom.2022.104298","volume":"85","author":"M Madhavan","year":"2022","unstructured":"Madhavan, M. et al. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial. eBioMedicine 85, 104298 (2022).","journal-title":"eBioMedicine"},{"key":"6809_CR37","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","volume":"396","author":"FC Zhu","year":"2020","unstructured":"Zhu, F. C. et al. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 396, 479\u2013488 (2020).","journal-title":"Lancet"},{"key":"6809_CR38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-2600(22)00087-X","volume":"10","author":"JX Li","year":"2022","unstructured":"Li, J. X. et al. Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial. Lancet Respir. Med. 10, 739\u2013748 (2022).","journal-title":"Lancet Respir. Med."},{"key":"6809_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2014.03.006","volume":"75","author":"QT Zhou","year":"2014","unstructured":"Zhou, Q. T., Tang, P., Leung, S. S., Chan, J. G. & Chan, H. K. Emerging inhalation aerosol devices and strategies: where are we headed? Adv. Drug Deliv. Rev. 75, 3\u201317 (2014).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"6809_CR40","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/jphp.12367","volume":"67","author":"AA Walters","year":"2015","unstructured":"Walters, A. A., Krastev, C., Hill, A. V. S. & Milicic, A. Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy. J. Pharm. Pharmacol. 67, 400\u2013408 (2015).","journal-title":"J. Pharm. Pharmacol."},{"key":"6809_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak, G. et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278 (2015).","journal-title":"Genome Biol."},{"key":"6809_CR42","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","volume":"182","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell 182, 1284\u20131294.e1289 (2020).","journal-title":"Cell"},{"key":"6809_CR43","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1038\/s41596-020-0394-5","volume":"15","author":"J Nie","year":"2020","unstructured":"Nie, J. et al. Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat. Protoc. 15, 3699\u20133715 (2020).","journal-title":"Nat. Protoc."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06809-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06809-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06809-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T05:06:24Z","timestamp":1703135184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06809-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":43,"journal-issue":{"issue":"7992","published-print":{"date-parts":[[2023,12,21]]}},"alternative-id":["6809"],"URL":"https:\/\/doi.org\/10.1038\/s41586-023-06809-8","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"29 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.W. and L.Z. are the inventors on patent application ZL202010175401.6 held or submitted by the Beijing Institute of Biotechnology related to CTB nanoparticles. G.M. is an inventor on patent application ZL201110401710.1 held or submitted by the Institute of Processing and Engineering related to porous microcapsules. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}